Evaluation of renal function: Use of serum creatinine concentration to assess level of kidney function

Nephrology

Volumn 10, Issue SUPPL. 4, 2005, Pages

  Johnson, David ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE;

ADULT; AGED; CHRONIC KIDNEY DISEASE; CONFERENCE PAPER; CREATININE BLOOD LEVEL; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; ISOTOPE DILUTION ASSAY; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; PRIORITY JOURNAL; SEX DIFFERENCE;

EID: 28544439704     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2005.00487_1.x     Document Type: Conference Paper

References (52)

1. Chadban SJ, Briganti EM, Kerr PG et al. Prevalence of kidney damage in Australian adults: The AusDiab kidney study, J. Am. Soc. Nephrol. 2003; 14 (7 Suppl. 2): S131-S138.
2. McClellan WM, Knight DF, Karp H et al. Early detection and treatment of renal disease in hospitalized diabetic and hypertensive patients: important differences between practice and published guidelines. Am. J. Kidney Dis 1997; 29: 368-75.
3. John R., Webb M, Young A et al. Unreferred chronic kidney disease: a longitudinal study. Am. J. Kidney Dis 2004; 43: 825-35.
4. McDonald S, Russ G. New Patients Commencing Renal Replacement Therapy in 2003. In: McDonald, S, Russ, G, eds. ANZDATA Registry Report 2003. Adelaide, SA: Australian and New Zealand Dialysis and Transplant Registry, 2005, 8-15.
5. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am. J. Kidney Dis 1998; 32 (5 Suppl. 3): S112-S119.
6. Weiner DE, Tighiouart H, Amin MG et al. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies, J. Am. Soc. Nephrol. 2004; 15: 1307-15.
7. Akbari A, Swedko PJ, Clark HD et al. Detection of chronic kidney disease with laboratory reporting of estimated glomerular filtration rate and an educational program. Arch. Intern. Med. 2004; 164: 1788-92.
8. Johnson CA, Levey AS, Coresh J et al. Clinical practice guidelines for chronic kidney disease in adults: Part 1. Definition, disease stages, evaluation, treatment, and risk factors. Am. Fam Physician 2004; 70: 869-76.
9. Coresh J, Astor BC, McQuillan G et al. Calibration and random variation of the serum creatinine assay as critical elements of using equations to estimate glomerular filtration rate. Am. J. Kidney Dis 2002; 39: 920-9.
10. Miller WG, Myers GL, Ashwood ER et al. Creatinine measurement: state of the art in accuracy and interlaboratory harmonization. Arch. Pathol Laboratory Med. 2005; 129: 297-304.
11. National Kidney Foundation. K/DOQI Clinical Practice Guidelines for Chronic Kidney Disease. Evaluation, Classification Stratification. Am. J. Kidney Dis 2002; 39 (Suppl. 1): S1-266.
12. Joint Specialty Committe of the Royal College of Physicians of London and the British Renal Association. Chronic Kidney Disease in Adults: UK Guidelines for Identification, Management and Referral. London: Royal College of Physicians of London and the British Renal Association, 2005. Available from URL: http://www.renal.org/CKDguide/full/UKCKDfull.pdf
13. Levey AS, Eckardt KU, Tsukamoto Y et al. Definition and classification of chronic kidney disease: a position statement from Kidney Disease. Improving Global Outcomes (KDIGO). Kidney Int. 2005; 67: 2089-100.
14. Young DS, Pestaner LC, Gibberman V. Effects of drugs on clinical laboratory tests. Clin. Chem. 1975, 21: 1D-432D.
15. Levey AS, Perrone RD, Madias NE. Serum creatinine and renal function. Annu. Rev. Med. 1988; 39: 465-90.
16. Levey AS, Bosch JP, Lewis JB et al. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification Diet Renal Dis Study Group. Ann. Intern. Med. 1999; 130: 461-70.
17. Lauture de H, Caces E, Dubost P. Concentrations of cholesterol, uric acid, urea, glucose and creatinine in a population of 50,000 active individuals. In: Siest, G, ed. Reference Values in Human Chemistry. Basel: Karger 1973, p. 141-52.
18. Mazzachi BC, Peake MJ, Ehrhardt V. Reference range and method comparison studies for enzymatic and Jaffe creatinine assays in plasma and serum and early morning urine. Clin. Laboratory 2000; 46: 53-5.
19. Sugita O, Uchiyama K, Yamada T et al. Reference values of serum and urine creatinine, and of creatinine clearance by a new enzymatic method. Ann. Clin. Biochem. 1992; 29: 523-8.
20. Iseki K, Ikemiya Y, Fukiyama K. Risk factors of end-stage renal disease and serum creatinine in a community-based mass screening. Kidney Int. 1997; 51: 850-4.
21. Couchoud C, Pozet N, Labeeuw M et al. Screening early renal failure: cut-off values for serum creatinine as an indicator of renal impairment. Kidney Int. 1999; 55: 1878-84.
22. Clase CM, Garg AX, Kiberd BA. Prevalence of low glomerular filtration rate in nondiabetic Americans. Third National Health and Nutrition Examination Survey (NHANES III), J. Am. Soc. Nephrol. 2002; 13: 1338-9.
23. Duncan L, Heathcote J, Djurdjev O et al. Screening for renal disease using serum creatinine: who are we missing? Nephrol. Dial Transplant 2001; 16: 1042-6.
24. Swedko PJ, Clark HD, Paramsothy K et al. Serum creatinine is an inadequate screening test for renal failure in elderly patients. Arch. Intern. Med. 2003; 163: 356-60.
25. Gumming RG, Mitchell P, Craig JC et al. Renal impairment and anaemia in a population-based study of older people. Intern. Med. J. 2004; 34: 20-3.
26. Wannamethee SG, Shaper AG, Perry IJ. Serum creatinine concentration and risk of cardiovascular disease, a possible marker for increased risk of stroke. Stroke 1997; 28: 557-63.
27. Ruilope LM, Salvetti A, Jamerson K et al. Renal function and intensive lowering of blood pressure in hypertensive participants of the Hypertension Optimal Treatment (HOT) Study, J. Am. Soc. Nephrol. 2001; 12: 218-25.
28. Mann JF, Gerstein HC, Pogue J et al. Renal insufficiency as a predictor of cardiovascular outcomes and the impact of ramipril: the HOPE randomized trial. Ann. Intern. Med. 2001; 134: 629-36.
29. Langford HG, Stamler J, Wassertheil-Smoller S etal. All-cause mortality in the Hypertension Detection and Follow-up Program: findings for the whole cohort and for persons with less severe hypertension, with and without other traits related to risk of mortality. Prog. Cardiovasc Dis 1986; 29 (3 Suppl. 1): S29-S54.
30. Drey N, Roderick P, Mullee M et al. A population-based study of the incidence and outcomes of diagnosed chronic kidney disease. Am. J. Kidney Dis 2003; 42: 677-84.
31. Shlipak MG, Simon JA, Grady D etal. Renal insufficiency and cardiovascular events in postmenopausal women with coronary heart disease, J. Am. Coll Cardiol. 2001; 38: 705-11.
32. Shlipak MG, Heidenreich PA, Noguchi H et al. Association of renal insufficiency with treatment and outcomes after myocardial infarction in elderly patients. Ann. Intern. Med. 2002; 137: 555-62.
33. Muntner P, He J, Hamm L etal. Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States. J. Am. Soc. Nephrol. 2002; 13: 745-53.
34. Shulman NB, Ford CE, Hall WD et al. Prognostic value of serum creatinine and effect of treatment of hypertension on renal function: results from the Hypertension Detection and Follow-up Program. Hypertension 1989; 13: 180-93.
35. Culleton BF, Larson MG, Wilson PW et al. Cardiovascular disease and mortality in a community-based cohort with mild renal insufficiency. Kidney Int. 1999; 56: 2214-9.
36. Garg AX, Clark WF, Haynes RB et al. Moderate renal insufficiency and the risk of cardiovascular mortality: results from the NHANES I. Kidney Int. 2002; 61: 1486-94.
37. Shlipak MG, Sarnak MJ, Kat Z. R. et al. Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl. J. Med. 2005; 352: 2049-60.
38. Wuyts B, Van den Bernard D, NN et al. Reevaluation of formulas for predicting creatinine clearance in adults and children, using compensated creatinine methods. Clin. Chem. 2003; 49: 1011-4.
39. Appel LJ, Champagne CM, Harsha DW et al. Effects of comprehensive lifestyle modification on blood pressure control: main results of the PREMIER clinical trial. JAMA 2003; 289: 2083-93.
40. Van Lente F, Suit P. Assessment of renal function by serum creatinine and creatinine clearance: glomerular filtration rate estimated by four procedures. Clin. Chem. 1989; 35: 2326-30.
41. Coresh J, Toto RD, Kirk KA et al. Creatinine clearance as a measure of GFR in screenees for the African-American Study of Kidney Disease and Hypertension pilot study. Am. J. Kidney Dis 1998; 32: 32-42.
42. Perrone RD, Madias NE, Levey AS. Serum creatinine as an index of renal function: new insights into old concepts. Clin. Chem. 1992; 38: 1933-53.
43. Ross JW, Miller WG, Myers GL et al. The accuracy of laboratory measurements in clinical chemistry: a study of 11 routine chemistry analytes in the College of American Pathologists Chemistry Survey with fresh frozen serum, definitive methods, and reference methods. Arch. Pathol Laboratory Med. 1998; 122: 587-608.
44. Hsu CY, Chertow GM, Curhan GC. Methodological issues in studying the epidemiology of mild to moderate chronic renal insufficiency. Kidney Int. 2002; 61: 1567-76.
45. Perrone RD, Steinman TI, Beck GJ et al. Utility of radioisotopic filtration markers in chronic renal insufficiency: simultaneous comparison of 1251-iothalamate, 169Yb-DTPA, 99mTc-DTPA, and inulin. The Modification Diet Renal Dis Study. Am. J. Kidney Dis 1990; 16: 224-35.
46. Berlyne GM, Varley H, Nilwarangkur S et al. Endogenous creatinine clearance and glomerular filtration rate. Lancet 1964; 22: 874-6.
47. Dunn SR, Gabuzda GM, Superdock KR et al. Induction of creatininase activity in chronic renal failure: timing of creatinine degradation and effect of antibiotics. Am. J. Kidney Dis 1997; 29: 72-7.
48. Mitch WE, Collier VU, Walser M. Creatinine metabolism in chronic renal failure. Clin. Sci. (Lond.) 1980; 58: 327-35.
49. Rapoport A, Husdan H. Endogenous creatinine clearance and serum creatinine in the clinical assessment of kidney function. Can Med. Assoc J. 1968; 99: 149-56.
50. Pasternack A, Kuhlback B. Diurnal variations of serum and urine creatine and creatinine. Scand. J. Clin. Laboratory Invest 1971; 27: 1-7.
51. Polkinghorne KR, Chadban SJ, Shaw JE et al. Prevalence of impaired GFR in Australia: a comparison between the Cockcroft-Gault and Modification of Diet in Renal Disease equations. Nephrology 2005; 10 (Suppl).
52. Rustad P. Reference intervals for 25 of the most frequently used properties in clinical chemistry: proposal by the NORDIC Reference Interval Project (NORIP). Klinisk Biokemi I Norden 2003; 15: 10-7.